Psioxus Therapeutics

Psioxus Therapeutics

Psioxus Therapeutics

Immuno-oncology specialists with a clinical stage oncolytic virus program and the T-SIGn plaform for immuno-gene-therapy
Founded
2010
Raised
$73.4M
Follow us
Featured on
Alexa global traffic share
Twitter followers
19 May 2015
$39,241,539
Venture capital (Series C)
09 Jul 2012
$34,118,753
Venture capital (Series B)